Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Sexually Transmitted Infection | Research article

HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey

Authors: Ndeye Aïssatou Lakhe, Khardiata Diallo Mbaye, Khadime Sylla, Cheikh Tidiane Ndour

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Despite the adoption of the provider-initiated HIV testing strategy, the rate of HIV testing is still very low in sub-Saharan Africa. The aim of this study was to assess the factors associated with HIV testing among sexually active women and men in Senegal. Knowledge of HIV status is the gateway to antiretroviral treatment.

Methods

A secondary analysis of the 2017 Senegal Demographic and Health Survey (DHS) was performed, using data on sexually active women aged 15–49 and men aged 15–59. The outcome variable was the proportion of women and men who reported ever being tested for HIV in the last 12 months before the survey. Descriptive, bivariate, and multivariable logistic regression analyses were performed to identify the socio-demographic, HIV-knowledge, media exposure, and behavioral factors associated with HIV testing in Senegal.

Results

The study found that 61.1% (95%CI: 59.2–62.9) of women and 26.2% (95%CI: 24.2–28.3) of men were tested for HIV at the last 12 months. In multivariate analysis, among men the factors independently associated with being tested for HIV were: age groups 20–24 to 40–44 and age group 50–54; a higher level of education; being in the richest household wealth quintile; being married; knowing about the efficacy of HAART during pregnancy; having 2 or more lifetime sex partners and owning a mobile phone. Among women factors independently associated with HIV testing were: being in any age groups versus 15–19; a higher level of education; being in the richest household wealth quintile; being married; knowing about the efficacy of HAART during pregnancy; having any STI in last 12 months; fearing stigma; owning a mobile phone; and having any number of ANC visits, versus none.

Conclusion

Although HIV remains a public health threat, HIV testing’s prevalence is still low in Senegal, making it difficult to interrupt the transmission chain within the community and to reach the UNAIDS goal for 2020 of “90–90-90”. Innovative community-based strategies are needed to address barriers and improve access to HIV testing in Senegal, particularly for men and for the youngest and poorest populations.
Literature
2.
go back to reference HIV/AIDS National Council of Senegal. Senegal: HIV/AIDS national strategic plan 2018–2022. Senegal: CNLS; 2018. HIV/AIDS National Council of Senegal. Senegal: HIV/AIDS national strategic plan 2018–2022. Senegal: CNLS; 2018.
8.
go back to reference Asaolu IO, Gunn JK, Center KE, Koss MP, Iwelunmor JI, Ehiri JE. Predictors of HIV testing among youth in sub-Saharan Africa: a cross-sectional study. PLoS One. 2016;11(10):e0164052.CrossRef Asaolu IO, Gunn JK, Center KE, Koss MP, Iwelunmor JI, Ehiri JE. Predictors of HIV testing among youth in sub-Saharan Africa: a cross-sectional study. PLoS One. 2016;11(10):e0164052.CrossRef
9.
go back to reference Staveteig S, Croft TN, Kampa KT, Head SK. Reaching the “first 90”: gaps in coverage of HIV testing among people living with HIV in 16 African countries. PLoS One. 2017;12(10):e0186316.CrossRef Staveteig S, Croft TN, Kampa KT, Head SK. Reaching the “first 90”: gaps in coverage of HIV testing among people living with HIV in 16 African countries. PLoS One. 2017;12(10):e0186316.CrossRef
10.
go back to reference Takarinda KC, Madyira LK, Mhangara M, Makaza V, Maphosa-Mutsaka M, Rusakaniko S, et al. Factors associated with ever being HIV-tested in Zimbabwe: an extended analysis of the Zimbabwe demographic and health survey (2010-2011). PLoS One. 2016;11(1):e0147828.CrossRef Takarinda KC, Madyira LK, Mhangara M, Makaza V, Maphosa-Mutsaka M, Rusakaniko S, et al. Factors associated with ever being HIV-tested in Zimbabwe: an extended analysis of the Zimbabwe demographic and health survey (2010-2011). PLoS One. 2016;11(1):e0147828.CrossRef
12.
go back to reference Agha S. Factors associated with HIV testing and condom use in Mozambique: implications for programs. Reprod Health. 2012;9:20.CrossRef Agha S. Factors associated with HIV testing and condom use in Mozambique: implications for programs. Reprod Health. 2012;9:20.CrossRef
13.
go back to reference Jean K, Anglaret X, Moh R, Lert F, Dray-Spira R. Barriers to HIV testing in Côte d’Ivoire: the role of individual characteristics and testing modalities. PLoS One. 2012;7(7):e41353.CrossRef Jean K, Anglaret X, Moh R, Lert F, Dray-Spira R. Barriers to HIV testing in Côte d’Ivoire: the role of individual characteristics and testing modalities. PLoS One. 2012;7(7):e41353.CrossRef
14.
go back to reference Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13:220.CrossRef Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13:220.CrossRef
15.
go back to reference Center KE, Gunn JKL, Asaolu IO, Gibson SJ, Ehiri JE. Contraceptive use and uptake of HIV-testing among sub-Saharan African women. PLoS One. 2016;11(4):e0154213.CrossRef Center KE, Gunn JKL, Asaolu IO, Gibson SJ, Ehiri JE. Contraceptive use and uptake of HIV-testing among sub-Saharan African women. PLoS One. 2016;11(4):e0154213.CrossRef
16.
go back to reference Abiodun O, Sotunsa J, Ani F, Jaiyesimi E. Knowledge of HIV/AIDS and predictors of uptake of HIV counseling and testing among undergraduate students of a privately owned university in Nigeria. BMC Res Notes. 2014;7:639.CrossRef Abiodun O, Sotunsa J, Ani F, Jaiyesimi E. Knowledge of HIV/AIDS and predictors of uptake of HIV counseling and testing among undergraduate students of a privately owned university in Nigeria. BMC Res Notes. 2014;7:639.CrossRef
18.
go back to reference Sambisa W, Curtis S, Mishra V. AIDS stigma as an obstacle to uptake of HIV testing: evidence from a Zimbabwean national population-based survey. AIDS Care. 2010;22(2):170–86.CrossRef Sambisa W, Curtis S, Mishra V. AIDS stigma as an obstacle to uptake of HIV testing: evidence from a Zimbabwean national population-based survey. AIDS Care. 2010;22(2):170–86.CrossRef
21.
go back to reference Sanga Z, Kapanda G, Msuya S, Mwangi R. Factors influencing the uptake of voluntary HIV counseling and testing among secondary school students in Arusha city, Tanzania: a cross sectional study. BMC Public Health. 2015;15:452.CrossRef Sanga Z, Kapanda G, Msuya S, Mwangi R. Factors influencing the uptake of voluntary HIV counseling and testing among secondary school students in Arusha city, Tanzania: a cross sectional study. BMC Public Health. 2015;15:452.CrossRef
22.
go back to reference MacPhail C, Pettifor A, Moyo W, Rees H. Factors associated with HIV testing among sexually active south African youth aged 15-24 years. AIDS Care. 2009;21(4):456–67.CrossRef MacPhail C, Pettifor A, Moyo W, Rees H. Factors associated with HIV testing among sexually active south African youth aged 15-24 years. AIDS Care. 2009;21(4):456–67.CrossRef
23.
go back to reference Van Handel M, Kann L, Olsen EO, Dietz P. HIV testing among US high school students and young adults. Pediatrics. 2016;137(2):e20152700.CrossRef Van Handel M, Kann L, Olsen EO, Dietz P. HIV testing among US high school students and young adults. Pediatrics. 2016;137(2):e20152700.CrossRef
24.
go back to reference Mahande MJ, Phimemon RN, Ramadhani HO. Factors associated with changes in uptake of HIV testing among young women (aged 15-24) in Tanzania from 2003 to 2012. Infect Dis Poverty. 2016;5(1):92.CrossRef Mahande MJ, Phimemon RN, Ramadhani HO. Factors associated with changes in uptake of HIV testing among young women (aged 15-24) in Tanzania from 2003 to 2012. Infect Dis Poverty. 2016;5(1):92.CrossRef
25.
go back to reference Idele P, Gillespie A, Porth T, Suzuki C, Mahy M, Kasedde S, et al. Epidemiology of HIV and AIDS among adolescents: current status, inequities, and data gaps. J Acquir Immune Defic Syndr 1999. 2014;66(Suppl 2):S144–53.CrossRef Idele P, Gillespie A, Porth T, Suzuki C, Mahy M, Kasedde S, et al. Epidemiology of HIV and AIDS among adolescents: current status, inequities, and data gaps. J Acquir Immune Defic Syndr 1999. 2014;66(Suppl 2):S144–53.CrossRef
27.
go back to reference Alabi AD, Oke OA, Adedokun BO, Runsewe-Abiodun TI. Perception and practice of HIV/AIDS counseling and testing among secondary school adolescents in Ogun waterside local government area, Ogun state, Southwest Nigeria. Int Q Community Health Educ. 2018;38(3):175–80.CrossRef Alabi AD, Oke OA, Adedokun BO, Runsewe-Abiodun TI. Perception and practice of HIV/AIDS counseling and testing among secondary school adolescents in Ogun waterside local government area, Ogun state, Southwest Nigeria. Int Q Community Health Educ. 2018;38(3):175–80.CrossRef
28.
go back to reference Kitara DL, Aloyo J. HIV/AIDS stigmatization, the reason for poor access to HIV counseling and testing (HCT) among the youths in Gulu (Uganda). Afr J Infect Dis. 2012;6(1):12–20.PubMedPubMedCentral Kitara DL, Aloyo J. HIV/AIDS stigmatization, the reason for poor access to HIV counseling and testing (HCT) among the youths in Gulu (Uganda). Afr J Infect Dis. 2012;6(1):12–20.PubMedPubMedCentral
30.
go back to reference Nangendo J, Obuku EA, Kawooya I, Mukisa J, Nalutaaya A, Musewa A, et al. Diagnostic accuracy and acceptability of rapid HIV oral testing among adults attending an urban public health facility in Kampala, Uganda. PloS One. 2017;12(8):e0182050.CrossRef Nangendo J, Obuku EA, Kawooya I, Mukisa J, Nalutaaya A, Musewa A, et al. Diagnostic accuracy and acceptability of rapid HIV oral testing among adults attending an urban public health facility in Kampala, Uganda. PloS One. 2017;12(8):e0182050.CrossRef
35.
go back to reference Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949–65.CrossRef Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949–65.CrossRef
36.
go back to reference Johnson CC, Kennedy C, Fonner V, Siegfried N, Figueroa C, Dalal S, et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21594.CrossRef Johnson CC, Kennedy C, Fonner V, Siegfried N, Figueroa C, Dalal S, et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21594.CrossRef
37.
go back to reference Tun W, Vu L, Dirisu O, Sekoni A, Shoyemi E, Njab J, et al. Uptake of HIV self-testing and linkage to treatment among men who have sex with men (MSM) in Nigeria: a pilot programme using key opinion leaders to reach MSM. J Int AIDS Soc. 2018;21(Suppl 5):e25124.CrossRef Tun W, Vu L, Dirisu O, Sekoni A, Shoyemi E, Njab J, et al. Uptake of HIV self-testing and linkage to treatment among men who have sex with men (MSM) in Nigeria: a pilot programme using key opinion leaders to reach MSM. J Int AIDS Soc. 2018;21(Suppl 5):e25124.CrossRef
38.
go back to reference Wolfe WR, Weiser SD, Leiter K, Steward WT, Percy-de Korte F, Phaladze N, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98(10):1865–71.CrossRef Wolfe WR, Weiser SD, Leiter K, Steward WT, Percy-de Korte F, Phaladze N, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98(10):1865–71.CrossRef
39.
go back to reference Makoae LN, Portillo CJ, Uys LR, Dlamini PS, Greeff M, Chirwa M, et al. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care. 2009;21(11):1357–62.CrossRef Makoae LN, Portillo CJ, Uys LR, Dlamini PS, Greeff M, Chirwa M, et al. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care. 2009;21(11):1357–62.CrossRef
40.
go back to reference Land KJ, Boeras DI, Chen X-S, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol. 2019;4(1):46–54.CrossRef Land KJ, Boeras DI, Chen X-S, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol. 2019;4(1):46–54.CrossRef
41.
go back to reference Mugo PM, Micheni M, Shangala J, Hussein MH, Graham SM, Rinke de Wit TF, et al. Uptake and acceptability of oral HIV self-testing among community pharmacy clients in Kenya: a feasibility study. PloS One. 2017;12(1):e0170868.CrossRef Mugo PM, Micheni M, Shangala J, Hussein MH, Graham SM, Rinke de Wit TF, et al. Uptake and acceptability of oral HIV self-testing among community pharmacy clients in Kenya: a feasibility study. PloS One. 2017;12(1):e0170868.CrossRef
43.
go back to reference World Health Organization. Guidelines on HIV self-testing and partner notification: supplement to Consolidated guidelines on HIV testing services. 2016. World Health Organization. Guidelines on HIV self-testing and partner notification: supplement to Consolidated guidelines on HIV testing services. 2016.
Metadata
Title
HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey
Authors
Ndeye Aïssatou Lakhe
Khardiata Diallo Mbaye
Khadime Sylla
Cheikh Tidiane Ndour
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4717-5

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue